These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24089160)

  • 1. Factors related with the progression of chronic kidney disease.
    Yuste C; Barraca D; Aragoncillo-Sauco I; Vega-Martínez A; Abad S; Verdalles-Guzmán Ú; Ruiz-Caro C; Ampuero J; López-Gómez JM
    Nefrologia; 2013; 33(5):685-91. PubMed ID: 24089160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTH levels and not serum phosphorus levels are a predictor of the progression of kidney disease in elderly patients with advanced chronic kidney disease.
    Toapanta Gaibor NG; Nava Pérez NC; Martínez Echevers Y; Montes Delgado R; Guerrero Riscos MÁ
    Nefrologia; 2017; 37(2):149-157. PubMed ID: 27823902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum phosphorus and the progression of advanced chronic kidney disease.
    Caravaca F; Villa J; García de Vinuesa E; Martínez del Viejo C; Martínez Gallardo R; Macías R; Ferreira F; Cerezo I; Hernández-Gallego R
    Nefrologia; 2011; 31(6):707-15. PubMed ID: 22130287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent risk factors associated with the decline of estimated GFR in CKD patients.
    Chang WX; Arai S; Tamura Y; Kumagai T; Ota T; Shibata S; Fujigaki Y; Shen ZY; Uchida S
    Clin Exp Nephrol; 2016 Feb; 20(1):58-70. PubMed ID: 26100399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
    Sturm G; Kollerits B; Neyer U; Ritz E; Kronenberg F;
    Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for progression of renal disease in patient with diabetic nephropathy.
    Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematuria increases progression of advanced proteinuric kidney disease.
    Yuste C; Rubio-Navarro A; Barraca D; Aragoncillo I; Vega A; Abad S; Santos A; Macias N; Mahillo I; Gutiérrez E; Praga M; Egido J; López-Gómez JM; Moreno JA
    PLoS One; 2015; 10(5):e0128575. PubMed ID: 26016848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and detection of chronic kidney disease (CKD)-related metabolic complications as a function of estimated glomerular filtration rate in the oldest old.
    Van Pottelbergh G; Vaes B; Jadoul M; Matheï C; Wallemacq P; Degryse JM
    Arch Gerontol Geriatr; 2012; 54(3):e419-25. PubMed ID: 22265240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K; Masajtis-Zagajewska A; Nowicki M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective controlled study of living kidney donors: three-year follow-up.
    Kasiske BL; Anderson-Haag T; Israni AK; Kalil RS; Kimmel PL; Kraus ES; Kumar R; Posselt AA; Pesavento TE; Rabb H; Steffes MW; Snyder JJ; Weir MR
    Am J Kidney Dis; 2015 Jul; 66(1):114-24. PubMed ID: 25795073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics.
    Devetzis V; Daryadel A; Roumeliotis S; Theodoridis M; Wagner CA; Hettwer S; Huynh-Do U; Ploumis P; Arampatzis S
    PLoS One; 2015; 10(12):e0143524. PubMed ID: 26630274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral paricalcitol as antiproteinuric agent in chronic kidney disease.
    de Lorenzo A; Salanova L; Bomback AS; Moya M; Coronel F; Bernis C; Sánchez-Tomero JA; Álvarez V
    Nefrologia; 2013; 33(5):709-15. PubMed ID: 24089163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.
    Heras M; Fernández-Reyes MJ; Sánchez R; Guerrero MT; Molina A; Rodríguez MA; Alvarez-Ude F
    Nefrologia; 2012 May; 32(3):300-5. PubMed ID: 22508140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between glomerular filtration rate, uric acid, and parathyroid hormone in children].
    Diallo D; Dubourg L; Ranchin B; Cochat P; Bacchetta J
    Arch Pediatr; 2013 Jun; 20(6):601-7. PubMed ID: 23642898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.
    González-Parra E; Aceña Á; Lorenzo Ó; Tarín N; González-Casaus ML; Cristóbal C; Huelmos A; Mahíllo-Fernández I; Pello AM; Carda R; Hernández-González I; Alonso J; Rodríguez-Artalejo F; López-Bescós L; Ortiz A; Egido J; Tuñón J
    J Bone Miner Metab; 2016 Sep; 34(5):587-98. PubMed ID: 26298279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.